MedTrace Logo

Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males

NCT03318731 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-09-25

No results posted yet for this study

Summary

This is a randomized, repeated measures and double blind study which measures the effect of fenugreek extract on markers of muscle damage and inflammation in non-resistance trained males. Participants will complete baseline testing and then be randomized into groups. Participants will complete a 2 week, split-body resistance training program. They will then return for testing in which they will complete an overreaching protocol for 5 consecutive days. Measurements will be recorded 24 hrs after the fifth day. Participants will resume the training program for one additional week and return for final measurements.

Conditions

Interventions

OTHER

Sugar Pill

Taken orally in capsule form

DIETARY_SUPPLEMENT

Fenugreek Extract, Low Dose

Taken orally in capsule form

DIETARY_SUPPLEMENT

Fenugreek Extract, High Dose

Taken orally in capsule form

Sponsors & Collaborators

  • Indus Biotech Ltd. Pvt.

    collaborator UNKNOWN

  • University of Mary Hardin-Baylor

    lead OTHER

Principal Investigators

  • Lemuel W Taylor IV, PhD · UMHB Human Performance Lab

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-21
Primary Completion
2019-05-24
Completion
2019-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03318731 on ClinicalTrials.gov